Concentriq drives the world's pathology
Concentriq is an enterprise pathology platform for all digital pathology data and AI applications. It bridges the gap between anatomic pathology laboratories and life sciences organizations, enabling real-world pathology data to fuel innovation that enhances patient care.
Enabling anatomic pathology laboratories to achieve 100% digitization and deliver faster, more precise results.
Driving efficiency and insight across the drug R&D value chain, from discovery to development.
Accelerate tomorrow’s breakthroughs today
Modern pathology software helps solve R&D’s biggest challenges. Improve data integrity and quality, run more studies and experiments faster and uncover new insights.
Run a modern, more productive lab
Accelerate your shift to 100% digital diagnosis to improve diagnostic quality, increase efficiency and position your lab for future growth.
AI-powered pathology for the modern laboratory
Concentriq delivers an open platform to serve as a hub for running a range of AI applications, including Proscia’s, your company’s own algorithms and a broad partner portfolio.
Concentriq® delivers value. Proscia delivers trust.
The 2024 KLAS Emerging Company Spotlight recognizes Concentriq as a digital pathology software that overcomes diagnostic challenges and improves lab efficiency.
Download your complimentary copy to get more details.
The data to fight cancer is in this image.
We’re helping labs and research centers take advantage of the collaboration, insight, accuracy and time-saving benefits of digital pathology, and accelerating breakthroughs in the fight against cancer. Learn more about our vision for powering this new era of data-driven pathology.
Latest News & Events
Event:
Digital Pathology and AI Congress EU (DPAIC)
December 11-12, 2024 | London, England
Visit Proscia at the Digital Pathology and AI Congress, where over 60 speakers will share the latest advances in digital pathology, AI, and machine learning. Visit our booth, meet our team and see a demo of our Concentriq enterprise software platform.
Webinar:
Unlocking The Promise of Foundation Models in Pathology For AI-Driven Drug Discovery & Development
Available On Demand
Proscia and Bioptimus share how foundation models can transform novel AI development in pathology. Our panel reveals practical strategies to unlock the full value of foundation models to enable faster pathology AI development that can impact all stages of drug discovery and development.
Study Report
Quest Diagnostics, Ibex Medical Analytics, and Proscia: Quantifying the Value of AI-Powered Digital Workflows in Real-World Diagnostic Laboratories
Blog
Introducing Proscia’s Real-World Data Offering: Empowering Life Sciences to Advance Precision Medicine Pipelines
Press Release
NOV. 19, 2024: Owkin And Proscia Expand Access To AI Pre-Screening For Colorectal Cancer Patients